Conmed Corp.’s filing revealed that its President AS and AET Peters Stanley W III unloaded Company’s shares for reported $0.25 million on Dec 04 ’23. In the deal valued at $109.93 per share,2,300 shares were sold. As a result of this transaction, Peters Stanley W III now holds 63 shares worth roughly $4492.53.
Then, Peters Stanley W III sold 1,200 shares, generating $122,874 in total proceeds. Upon selling the shares at $102.39, the President AS and AET now owns 63 shares.
Before that, Peters Stanley W III sold 2,000 shares. Conmed Corp. shares valued at $214,629 were divested by the President AS and AET at a price of $107.31 per share. As a result of the transaction, Peters Stanley W III now holds 63 shares, worth roughly $4492.53.
Needham reiterated its Conmed Corp. [CNMD] rating to a Buy in a research note published on February 01, 2024; the price target was $129. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. KeyBanc Capital Markets also remained covering CNMD and has increased its forecast on March 27, 2023 with a “an Overweight” recommendation from previously “Sector weight” rating. Wells Fargo started covering the stock on March 21, 2023. It rated CNMD as “an Equal weight”.
Price Performance Review of CNMD
On Tuesday, Conmed Corp. [NYSE:CNMD] saw its stock fall -1.79% to $71.31. Over the last five days, the stock has lost -7.94%. Conmed Corp. shares have fallen nearly -34.88% since the year began. Nevertheless, the stocks have fallen -38.63% over the past one year. While a 52-week high of $138.47 was reached on 01/12/24, a 52-week low of $70.57 was recorded on 04/18/24. SMA at 50 days reached $79.28, while 200 days put it at $99.78. A total of 0.53 million shares were traded, compared to the trading of 0.34 million shares in the previous session.
Levels Of Support And Resistance For CNMD Stock
The 24-hour chart illustrates a support level at 70.56, which if violated will result in even more drops to 69.81. On the upside, there is a resistance level at 72.66. A further resistance level may holdings at 74.01. The Relative Strength Index (RSI) on the 14-day chart is 34.80, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.66%. Stochastics %K at 16.04% indicates the stock is a buying.
The most recent change occurred on October 12, 2022 when Jefferies began covering the stock and recommended ‘”a Hold”‘ rating along with a $85 price target.
